Case of the Patient in Midlife: Weighing Potential Changes in ASCCP Guidelines
Host: Warner K. Huh, MD
\n\n Guest: Sarah E. Dilley, MD, MPH, FACOG
\n\n\n \n
Effective triage tests are needed to lessen diagnostic uncertainty when assessing cervical cancer risk and selecting which patients will move on to colposcopy. An FDA-approved dual-staining cytology test is available that can help in decision-making for a wide range of patients. Join Drs. Warner Huh and Sarah Dilley as they address current 2019 ASCCP guidelines and anticipate potential updates to ASCCP\u2019s guidance in 2023.